Send me a link:

*Text messaging rates may apply.

 Dow Down 0.19% Nasdaq Up 0.45%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NMS
35.65 Jul 30, 3:59PM EDT
|Pre-Market : 36.49 Up 0.84 (2.36%) 8:56AM EDT - Nasdaq Real Time Price
Prev Close:35.65
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:67.50
Beta:0.63
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:N/A - N/A
52wk Range:26.25 - 101.00
Volume:0
Avg Vol (3m):1,127,140
Market Cap:1.05B
P/E (ttm):N/A
EPS (ttm):-2.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AEGR

Comparison

Symbol% ChgMkt Cap
AEGR 0.00%1.05B
AZN92.29B
MRK170.79B
PFE186.64B

Key Statistics

Forward P/E (1 yr):15.92
P/S (ttm):10.13
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.93
Quarterly EPS Est (Sep-14) :-0.14
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback